Li, J., Xie, N., Yuan, J., Liu, L., Zhou, Q., Ren, X., . . . Wan, X. (2017). DcR3 combined with hematological traits serves as a valuable biomarker for the diagnosis of cancer metastasis. Oncotarget.
Chicago-tyylinen lähdeviittausLi, Junxin, et al. "DcR3 Combined With Hematological Traits Serves As a Valuable Biomarker for the Diagnosis of Cancer Metastasis." Oncotarget 2017.
MLA-viiteLi, Junxin, et al. "DcR3 Combined With Hematological Traits Serves As a Valuable Biomarker for the Diagnosis of Cancer Metastasis." Oncotarget 2017.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.